Teva Pharma (TEVA) weekly calls bid up on renewed takeover speculation
Tweet
Share
E-mail
Get Alerts TEVA Hot Sheet
Price: $12.94 +0.47%
Overall Analyst Rating:
NEUTRAL (= Flat)
Dividend Yield: 2.1%
EPS Growth %: +30.0%
Overall Analyst Rating:
NEUTRAL (= Flat)
Dividend Yield: 2.1%
EPS Growth %: +30.0%
Join SI Premium – FREE
Teva Pharma (NYSE: TEVA) November 44 and 44.50 weekly calls are active on total call volume of 6,700 contracts (850 puts) on renewed takeover speculation. November weekly call option implied volatility is at 39, November is at 41; compared to its 52-week range of 21 to 56. Teva is expected to report Q3 results on November 15.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pioneer Natural Resources (PXD) call put ratio 2.5 calls to 1 put into quarter results and outlook
- AT&T (T) call put ratio 3 calls to 1 put into quarter results and outlook
- Meta Platforms (META) ) April weekly option implied volatility into quarter results
Create E-mail Alert Related Categories
Options, Trader TalkRelated Entities
OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
